Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial
- 1 December 2002
- journal article
- Published by Elsevier in Clinical Prostate Cancer
- Vol. 1 (3) , 163-171
- https://doi.org/10.3816/cgc.2002.n.018
Abstract
No abstract availableKeywords
Funding Information
- Fonds Léon Fredericq
- AstraZeneca
- Fonds De La Recherche Scientifique - FNRS
This publication has 27 references indexed in Scilit:
- Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genesPublished by Elsevier ,2003
- Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft modelThe Prostate, 2000
- Intermittent Androgen Suppression: Too Good to be True?Scandinavian Journal of Urology and Nephrology, 1999
- Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinomaThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour modelThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995
- Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigenCancer, 1993
- Experimental Treatment of Prostatic Cancer by Intermittent Hormonal TherapyJournal of Urology, 1987
- Intermittent endocrine therapy for advanced prostate cancerCancer, 1986
- Sex Steroids as a Cause of Adenocarcinoma of the Dorsal Prostate in Nb Rats, and their Influence on the Growth of TransplantsOncology, 1977